As of 18 Sept 2026, Tatva Chintan Pharma Chem Ltd share price is ₹1,704.20. The stock opened at ₹1,704.20 and had closed at ₹1,644.15 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹988.00 and a high of ₹1,838.85. In terms of performance, Tatva Chintan Pharma Chem Ltd share price has increased by 39.00% over the past six months and has increased by 49.06% over the last year.
TATVA Stock Price Chart
Tatva Chintan Pharma Chem Ltd Overview
About TATVA
Tatva Chintan Pharma Chem is engaged in manufacturing, sale and distribution of specialty chemicals, viz., phase transfer catalysts (PTC), structure directing agents (SDA), electrolyte salts and solutions (ESS), pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC).
Tatva Chintan Pharma Chem Ltd Historical Performance
Tatva Chintan Pharma Chem Ltd Fundamentals
Tatva Chintan Pharma Chem Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 499.83 | 369.98 | 386.19 | 408.72 | 438.44 |
| EBITDA | 92.86 | 29.40 | 74.38 | 56.76 | 116.40 |
| Net Profit | 39.08 | 0.33 | 29.35 | 40.47 | 95.99 |
| EPS | 16.71 | 0.14 | 12.82 | 18.26 | 44.65 |
Tatva Chintan Pharma Chem Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,556.63 |
| Resistance 1 (R1) | 1,695.33 |
| Pivot Point | 1,607.82 |
Tatva Chintan Pharma Chem Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 11-Sep-2026 | 16-May-2026 | 11-Sep-2026 | Final | ₹2.00 |
| 12-Sep-2025 | 02-May-2025 | 12-Sep-2025 | Final | ₹1.00 |
| 06-Sep-2024 | 03-May-2024 | 07-Sep-2024 | Final | ₹2.00 |
| 08-Sep-2023 | 05-May-2023 | 08-Sep-2023 | Final | ₹2.00 |
| 08-Sep-2022 | 25-Apr-2022 | 09-Sep-2022 | Final | ₹2.00 |
TATVA Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Chintan Nitinkumar Shah | Chairman |
| Ajaykumar Mansukhlal Patel | WTD & Executive Directorector |
| Shekhar Rasiklal Somani | WTD & Executive Directorector |
Tatva Chintan Pharma Chem Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Pidilite Industries LtdPIDILITIND | ₹1,551.50+0.50% | ₹1,46,382.9 | 63.25 | 22.61% |
| SRF LtdSRF | ₹2,536.00+2.25% | ₹75,137.76 | 42.23 | 13.07% |
| Linde India LtdLINDEINDIA | ₹6,094.50+0.08% | ₹56,696.28 | 96.10 | 12.87% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Tatva Chintan Pharma Chem Ltd today is ₹1,704.20 on NSE and ₹1,704.20 on BSE.
- The 52-week high of Tatva Chintan Pharma Chem Ltd is ₹1,838.85, while the 52-week low is ₹988.00.
- The current market capitalisation of Tatva Chintan Pharma Chem Ltd is approximately ₹3,846 crore.
- The P/E (Price-to-Earnings) ratio of Tatva Chintan Pharma Chem Ltd is 78.77. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Tatva Chintan Pharma Chem Ltd is 3.42. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Tatva Chintan Pharma Chem Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for TATVA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Tatva Chintan Pharma Chem Ltd has delivered a return of approximately 0.23%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Tatva Chintan Pharma Chem Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 72.02% promoters, 1.15% FIIs, 3.11% DIIs, and 17.48% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
